- Joined
- Jul 9, 2019
- Messages
- 144
- Reaction score
- 154
I was wondering if anyone could provide more information on how much Medicare B reimburses pharmacies for filling prescriptions of diabetic testing supplies, nebulizer solutions, and insulin for pumps. I have worked for a chain pharmacy for years filling these Rxs and just happened upon this article from 2013:
If you don't care to read it, at least snipe the title off the link there about a number of pharmacies unwilling to fill Rxs that are a loss of money because Part B doesn't even cover the full cost of the drug. I know that a lot can happen between then and now, but it's got me thinking since reimbursement rates are already razor thin. Reimbursement rates have always lingered in my mind, but my company's policy is to fill the Rx as long as we meet all the necessary criteria. For example, we fax doctors a form to fill out for testing strips and as long as it's done correctly and accepted by our billing department, the Rx is filled for a very low copay (oftentimes $0 if the patient has a supplemental plan). Needless to say, these Rxs are expensive and time-consuming, so is the effort really worth it?
If pharmacies really are losing $ on these Rxs, why doesn't corporate just make a policy to just outright deny them? Note: filling the patient's other drugs is not a good answer to this last question, because quite a few patients use our pharmacy just to fill Part B scripts only.
Insight is appreciated-- especially if you have knowledge of what goes on behind the scenes (i.e. actual cost to the pharmacy to order these products and the actual reimbursement rates themselves). Thanks!
Pharmacies unwilling to take loss on insulin for Medicare patients
“It’s a huge issue. All these pharmacies have quit doing it. I understand. They have to make a profit to survive,” patient Lee Carr said.
journalstar.com
If you don't care to read it, at least snipe the title off the link there about a number of pharmacies unwilling to fill Rxs that are a loss of money because Part B doesn't even cover the full cost of the drug. I know that a lot can happen between then and now, but it's got me thinking since reimbursement rates are already razor thin. Reimbursement rates have always lingered in my mind, but my company's policy is to fill the Rx as long as we meet all the necessary criteria. For example, we fax doctors a form to fill out for testing strips and as long as it's done correctly and accepted by our billing department, the Rx is filled for a very low copay (oftentimes $0 if the patient has a supplemental plan). Needless to say, these Rxs are expensive and time-consuming, so is the effort really worth it?
If pharmacies really are losing $ on these Rxs, why doesn't corporate just make a policy to just outright deny them? Note: filling the patient's other drugs is not a good answer to this last question, because quite a few patients use our pharmacy just to fill Part B scripts only.
Insight is appreciated-- especially if you have knowledge of what goes on behind the scenes (i.e. actual cost to the pharmacy to order these products and the actual reimbursement rates themselves). Thanks!